0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover4260.99%IV-30.17%PremiumJul 19, 2024Expiry Date2.16Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8525Delta0.0745Gamma2.92Leverage Ratio-9.5859Theta0.0000Rho2.49Eff Leverage0.0002Vega
MiMedx Stock Discussion
In a recent move that underscores their confidence in the regenerative medicine sector, Mizuho Securities has maintained its 'Buy' rating on MiMedx Group Inc. (NASDAQ: MDXG) and has raised the price target from a previous estimate to $14. This comes as the company continues to make significant strides in its advanced wound care and surgical tissue solutions. $MiMedx(MDXG.US)$